Zsolt Markoczy

Budapest, BU, Hungary

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Economic evaluation of low-dose computed tomography for lung cancer screening among high-risk individuals - evidence from Hungary based on the HUNCHEST-II study.

Economic evaluation of low-dose computed tomography for lung cancer screening among high-risk individuals - evidence from Hungary based on the HUNCHEST-II study.

Journal: BMC health services research
Published: April 18, 2024

HUNCHEST-II contributes to a shift to earlier-stage lung cancer detection: final results of a nationwide screening program.

HUNCHEST-II contributes to a shift to earlier-stage lung cancer detection: final results of a nationwide screening program.

Journal: European radiology
Published: June 05, 2023

Chromosomal Aberrations in Blood Lymphocytes as Predictors of Respiratory Function After Stereotactic Lung Irradiation.

Chromosomal Aberrations in Blood Lymphocytes as Predictors of Respiratory Function After Stereotactic Lung Irradiation.

Journal: Frontiers in oncology
Published: December 06, 2021

Nationwide lung cancer screening with low-dose computed tomography: implementation and first results of the HUNCHEST screening program.

Nationwide lung cancer screening with low-dose computed tomography: implementation and first results of the HUNCHEST screening program.

Journal: European radiology
Published: November 08, 2021

First experiences with HUNCHEST - low-dose CT lung cancer screening programme

First experiences with HUNCHEST - low-dose CT lung cancer screening programme

Journal: Orvosi hetilap
Published: October 23, 2018

Erlotinib as single agent first line treatment in locally advanced or metastatic activating EGFR mutation-positive lung adenocarcinoma (CEETAC): an open-label, non-randomized, multicenter, phase IV clinical trial.

Erlotinib as single agent first line treatment in locally advanced or metastatic activating EGFR mutation-positive lung adenocarcinoma (CEETAC): an open-label, non-randomized, multicenter, phase IV clinical trial.

Journal: BMC cancer
Published: August 02, 2017

In Process Citation

In Process Citation

Journal: Magyar sebeszet
Published: June 19, 2015

Pseudomyxoma of the pleura and of the peritoneum -- case report of a rare disease

Pseudomyxoma of the pleura and of the peritoneum -- case report of a rare disease

Journal: Magyar sebeszet
Published: February 21, 2012
Showing 1-8 of 8

Last Updated: 09/26/2026